Axert Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Axert, and what generic alternatives are available?
Axert is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in AXERT is almotriptan malate. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Axert
A generic version of Axert was approved as almotriptan malate by TEVA PHARMS USA on July 7th, 2015.
Summary for Axert
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Patent Applications: | 395 |
Drug Prices: | Drug price information for Axert |
What excipients (inactive ingredients) are in Axert? | Axert excipients list |
DailyMed Link: | Axert at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for Axert
Paragraph IV (Patent) Challenges for AXERT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
AXERT | Tablets | almotriptan malate | 6.25 mg and 12.5 mg | 021001 | 1 | 2005-12-08 |
US Patents and Regulatory Information for Axert
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-001 | May 7, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-002 | May 7, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Axert
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-001 | May 7, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | AXERT | almotriptan malate | TABLET;ORAL | 021001-002 | May 7, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Axert
See the table below for patents covering Axert around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Russian Federation | 2117667 | INDOLE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION SHOWING SELECTIVE BINDING ACTIVITY WITH RESPECT TO 5--HT |
⤷ Try a Trial |
Finland | 941413 | ⤷ Try a Trial | |
Egypt | 20340 | Process for preparing of new indol derivatives | ⤷ Try a Trial |
Norway | 180231 | ⤷ Try a Trial | |
Brazil | 9305589 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for Axert
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0605697 | 9/2001 | Austria | ⤷ Try a Trial | PRODUCT NAME: ALMOTRIPTAN UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE; NAT. REGISTRATION NO/DATE: 1-23957, 1-23958 20010131; FIRST REGISTRATION: ES 62877 19991223 |
0605697 | C00605697/01 | Switzerland | ⤷ Try a Trial | FORMER OWNER: LABORATORIOS ALMIRALL, S.A., ES |
0605697 | C300053 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ALMOTRIPTAN DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH GESCHIKT ZOUT, IN HET BIJZONDER HET WATERSTOFMALAAT; REGISTRATION NO/DATE: RVG 25415 - RVG 25416 20010309 |
0605697 | SPC/GB01/008 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 1-(((3-(2-(DIMETHYLAMINO)ETHYL)INDOL-5-YL)METHYL)SULFONYL)PYRROLIDINE GENERIC NAME ALMOTRIPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY AS ALMOTRIPTAN D,L - HYDROGEN MALATE; REGISTERED: ES 62.877 19991223; UK PL 16973/0005 20001026 |
0605697 | SPC003/2001 | Ireland | ⤷ Try a Trial | SPC003/2001: 20041230, EXPIRES: 20141222 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |